166 related articles for article (PubMed ID: 9712461)
41. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
Leone PA; Trottier S; Miller JM
Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
[TBL] [Abstract][Full Text] [Related]
42. Systemic side effects of antiviral therapy in a patient with acute retinal necrosis.
Guney E; Akcay BI; Erdogan G; Unlu C; Bozkurt K; Onur U
Ocul Immunol Inflamm; 2014 Jun; 22(3):233-5. PubMed ID: 24063786
[TBL] [Abstract][Full Text] [Related]
43. A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil.
Royer B; Zanetta G; Bérard M; Davani S; Tanter Y; Rifle G; Kantelip JP
Clin Transplant; 2003 Apr; 17(2):158-61. PubMed ID: 12709084
[TBL] [Abstract][Full Text] [Related]
44. Valacyclovir for the treatment of genital herpes.
Brantley JS; Hicks L; Sra K; Tyring SK
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
[TBL] [Abstract][Full Text] [Related]
45. 6-Month follow-up of a case with psychosis triggered by valacyclovir.
Chan YE; Tsai CF
J Chin Med Assoc; 2018 Feb; 81(2):187-188. PubMed ID: 29198553
[No Abstract] [Full Text] [Related]
46. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
[TBL] [Abstract][Full Text] [Related]
47. Herpes drug study halted.
Posit Aware; 1995; ():5. PubMed ID: 11362376
[TBL] [Abstract][Full Text] [Related]
48. A case of acyclovir neurotoxicity presenting with atypical cerebrospinal fluid findings.
Thind GS; Roach R
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536235
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
50. [Randomized controlled multi-center trial for treatment of varicella in pediatric patients with hydrochloride valacyclovir].
Yu H; Zhu QR; Wang ZL; Li YF; Wang XH
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):454-6; discussion 456-7. PubMed ID: 19099786
[TBL] [Abstract][Full Text] [Related]
51. [Epilepticus status and valaciclovir in chronic renal failure].
Rodríguez Uranga JJ; Franco Macías E; Delgado López F; Villalobos Chávez F
Med Clin (Barc); 2004 Sep; 123(10):399. PubMed ID: 15482711
[No Abstract] [Full Text] [Related]
52. [Neurotoxicity after the first dose of oral administration of valaciclovir in a female hemodialyzed patient].
Saurina A; Ramírez de Arellano M; de las Cuevas X
Nefrologia; 2002; 22(1):83-4. PubMed ID: 11987691
[No Abstract] [Full Text] [Related]
53. Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection.
Reischig T; Jindra P; Mares J; Cechura M; Svecová M; Hes O; Opatrný K; Treska V
Transplantation; 2005 Feb; 79(3):317-24. PubMed ID: 15699762
[TBL] [Abstract][Full Text] [Related]
54. Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient.
Rivaud E; Massiani MA; Vincent F; Azoulay E; Coudrec LJ
Arch Intern Med; 2000 Jun; 160(11):1705-6. PubMed ID: 10847274
[No Abstract] [Full Text] [Related]
55. Valacyclovir-induced urticaria without acyclovir hypersensitivity.
Singh SK; Prabhu A; Kumar A
Indian J Dermatol Venereol Leprol; 2015; 81(6):611-2. PubMed ID: 26515842
[No Abstract] [Full Text] [Related]
56. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir.
Tucci DL; Farmer JC; Kitch RD; Witsell DL
Otol Neurotol; 2002 May; 23(3):301-8. PubMed ID: 11981385
[TBL] [Abstract][Full Text] [Related]
57. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System.
Yue Z; Shi J; Li H; Li H
Biol Pharm Bull; 2018 Feb; 41(2):158-162. PubMed ID: 29187701
[TBL] [Abstract][Full Text] [Related]
58. Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia.
Dickerson FB; Boronow JJ; Stallings CR; Origoni AE; Yolken RH
Am J Psychiatry; 2003 Dec; 160(12):2234-6. PubMed ID: 14638597
[TBL] [Abstract][Full Text] [Related]
59. [Valaciclovir].
Taéron C
Rev Infirm; 2007 Dec; (136):47-8. PubMed ID: 18257501
[No Abstract] [Full Text] [Related]
60. Valaciclovir (BW256U87): the L-valyl ester of acyclovir.
Jacobson MA
J Med Virol; 1993; Suppl 1():150-3. PubMed ID: 8245883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
